Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS · Delayed Price · Currency is USD
0.0507
0.00 (0.00%)
Mar 4, 2026, 3:58 PM EST
Nymox Pharmaceutical Market Cap
Nymox Pharmaceutical has a market cap or net worth of $5.42 million as of March 5, 2026. Its market cap has decreased by -17.20% in one year.
Market Cap
5.42M
Enterprise Value
8.63M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since November 26, 1997, Nymox Pharmaceutical's market cap has decreased from 118.04M to 5.42M, a decrease of -95.41%. That is a compound annual growth rate of -10.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 5.17M | 26.12% |
| Dec 31, 2025 | 4.10M | -56.61% |
| Dec 31, 2024 | 9.45M | -82.82% |
| Dec 29, 2023 | 55.03M | 86.49% |
| Dec 30, 2022 | 29.51M | -73.23% |
| Dec 31, 2021 | 110.23M | -42.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Brainstorm Cell Therapeutics | 7.72M |
| TRON Group | 7.38M |
| AccuStem Sciences | 7.07M |
| Synlogic | 7.01M |
| Orgenesis | 5.90M |
| BetterLife Pharma | 5.83M |
| Mosaic ImmunoEngineering | 5.10M |
| Bioxytran | 4.75M |